Financials data is unavailable for this security.
View more
Year on year Shanghai MicroPort EP Medtech Co Ltd grew revenues 26.46% from 260.32m to 329.19m while net income improved 85.17% from 3.07m to 5.69m.
Gross margin | 57.86% |
---|---|
Net profit margin | 9.35% |
Operating margin | 9.92% |
Return on assets | 1.95% |
---|---|
Return on equity | 2.10% |
Return on investment | 2.05% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Shanghai MicroPort EP Medtech Co Ltd fell by 322.59m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 37.97m for operations while cash used for investing totalled 274.66m.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 3.68 |
---|---|
Tangible book value per share | 3.45 |
More ▼
Balance sheet in CNYView more
Current ratio | 15.07 |
---|---|
Quick ratio | 13.82 |
Total debt/total equity | 0.011 |
---|---|
Total debt/total capital | 0.0109 |
More ▼